id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02536794
|
,27:59:treatment
|
within 12 months of their last adjuvant systemic treatment
| 1
|
[
"within",
"12",
"months",
"of",
"their",
"last",
"adjuvant",
"systemic",
"treatment"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT03011684
|
20:39:treatment,44:60:treatment,70:86:treatment
|
Desires to undergo ovarian stimulation and oocyte retrieval prior to cancer treatment
| 1
|
[
"Desires",
"to",
"undergo",
"ovarian",
"stimulation",
"and",
"oocyte",
"retrieval",
"prior",
"to",
"cancer",
"treatment"
] |
[
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
1,
1
] |
NCT02479906
|
1:26:chronic_disease,
|
Transient ischemic attack within two years
| 1
|
[
"Transient",
"ischemic",
"attack",
"within",
"two",
"years"
] |
[
2,
2,
2,
0,
0,
0
] |
NCT03022292
|
1:44:treatment
|
Prior or current systemic anti-VEGF therapy
| 1
|
[
"Prior",
"or",
"current",
"systemic",
"anti-VEGF",
"therapy"
] |
[
1,
1,
1,
1,
1,
1
] |
NCT02165449
|
35:65:chronic_disease
|
Diagnosis: DSM-IV TR criteria for non-psychotic major depression
| 1
|
[
"Diagnosis",
":",
"DSM-IV",
"TR",
"criteria",
"for",
"non-psychotic",
"major",
"depression"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02131467
|
,,,46:71:chronic_disease
|
18-65 year old male and female patients with primary cervical dystonia
| 1
|
[
"18-65",
"year",
"old",
"male",
"and",
"female",
"patients",
"with",
"primary",
"cervical",
"dystonia"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT00291525
|
22:34:chronic_disease
|
Patients with active endocarditis at the time of implant
| 1
|
[
"Patients",
"with",
"active",
"endocarditis",
"at",
"the",
"time",
"of",
"implant"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02079857
|
1:15:chronic_disease
|
Alarm symptoms according to ROME III
| 1
|
[
"Alarm",
"symptoms",
"according",
"to",
"ROME",
"III"
] |
[
2,
2,
0,
0,
0,
0
] |
NCT02340156
|
39:57:allergy_name
|
Have a history of hypersensitivity to dacarbazine (DTIC)
| 1
|
[
"Have",
"a",
"history",
"of",
"hypersensitivity",
"to",
"dacarbazine",
"(",
"DTIC",
")"
] |
[
0,
0,
0,
0,
0,
0,
4,
4,
0,
0
] |
NCT01754298
|
1:13:treatment
|
chemotherapy treatment
| 1
|
[
"chemotherapy",
"treatment"
] |
[
1,
0
] |
NCT01626079
|
1:46:treatment,
|
Transcatheter aortic valve replacement (TAVR) within 30 days prior to subject registration
| 1
|
[
"Transcatheter",
"aortic",
"valve",
"replacement",
"(",
"TAVR",
")",
"within",
"30",
"days",
"prior",
"to",
"subject",
"registration"
] |
[
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02159495
|
53:63:cancer
|
Research participants with presence of other active malignancy
| 1
|
[
"Research",
"participants",
"with",
"presence",
"of",
"other",
"active",
"malignancy"
] |
[
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT01505569
|
53:63:cancer
|
All patients must have histological verification of malignancy at original diagnosis
| 1
|
[
"All",
"patients",
"must",
"have",
"histological",
"verification",
"of",
"malignancy",
"at",
"original",
"diagnosis"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0
] |
NCT02315612
|
1:18:cancer,33:61:cancer,74:79:cancer,
|
Second malignancy other than in situ carcinoma of the cervix, unless the tumor was treated with curative intent at least two years previously and subject is in remission
| 1
|
[
"Second",
"malignancy",
"other",
"than",
"in",
"situ",
"carcinoma",
"of",
"the",
"cervix",
",",
"unless",
"the",
"tumor",
"was",
"treated",
"with",
"curative",
"intent",
"at",
"least",
"two",
"years",
"previously",
"and",
"subject",
"is",
"in",
"remission"
] |
[
3,
3,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02979366
|
12:15:chronic_disease
|
arriers of HIV antibodies
| 1
|
[
"arriers",
"of",
"HIV",
"antibodies"
] |
[
0,
0,
2,
0
] |
NCT02252081
|
27:45:treatment,
|
Recent hospitalization or surgical procedure within 1 month prior to the study for any cause
| 1
|
[
"Recent",
"hospitalization",
"or",
"surgical",
"procedure",
"within",
"1",
"month",
"prior",
"to",
"the",
"study",
"for",
"any",
"cause"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02207465
|
1:6:cancer,
|
Tumor abutment to SMA but not to exceed greater than 180 degrees of circumferential vessel wall
| 1
|
[
"Tumor",
"abutment",
"to",
"SMA",
"but",
"not",
"to",
"exceed",
"greater",
"than",
"180",
"degrees",
"of",
"circumferential",
"vessel",
"wall"
] |
[
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03076333
|
20:30:cancer,
|
History of a prior malignancy within past 5 years
| 1
|
[
"History",
"of",
"a",
"prior",
"malignancy",
"within",
"past",
"5",
"years"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
0
] |
NCT03037385
|
75:88:treatment
|
Patients in Groups 1-5 and 7 (Part 2) previously treated with a selective RET inhibitor
| 1
|
[
"Patients",
"in",
"Groups",
"1-5",
"and",
"7",
"(",
"Part",
"2",
")",
"previously",
"treated",
"with",
"a",
"selective",
"RET",
"inhibitor"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03054519
|
,,,59:77:treatment
|
have an ABI > 0.90 with a 20% or higher drop in ABI after heel-rise exercise will be eligible
| 1
|
[
"have",
"an",
"ABI",
">",
"0.90",
"with",
"a",
"20",
"%",
"or",
"higher",
"drop",
"in",
"ABI",
"after",
"heel-rise",
"exercise",
"will",
"be",
"eligible"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT03038620
|
39:63:treatment,
|
Current participation in an organized weight reduction program or within the last 1 month prior to screening for this trial
| 1
|
[
"Current",
"participation",
"in",
"an",
"organized",
"weight",
"reduction",
"program",
"or",
"within",
"the",
"last",
"1",
"month",
"prior",
"to",
"screening",
"for",
"this",
"trial"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02457845
|
48:59:cancer,54:59:cancer,71:94:cancer,96:119:cancer,121:143:cancer,145:176:cancer,178:188:cancer,190:222:cancer,224:239:cancer,344:351:treatment,353:365:treatment,374:386:treatment
|
Pathologically proven malignant supratentorial brain tumor (including glioblastoma multiforme, giant cell glioblastoma, anaplastic astrocytoma, primitive neuroectodermal tumor, ependymoma, atypical teratoid/rhabdoid tumor, germ cell tumor, or other high-grade malignant tumor) which is progressive or recurrent despite standard care including surgery, radiotherapy, and/or chemotherapy
| 1
|
[
"Pathologically",
"proven",
"malignant",
"supratentorial",
"brain",
"tumor",
"(",
"including",
"glioblastoma",
"multiforme",
",",
"giant",
"cell",
"glioblastoma",
",",
"anaplastic",
"astrocytoma",
",",
"primitive",
"neuroectodermal",
"tumor",
",",
"ependymoma",
",",
"atypical",
"teratoid/rhabdoid",
"tumor",
",",
"germ",
"cell",
"tumor",
",",
"or",
"other",
"high-grade",
"malignant",
"tumor",
")",
"which",
"is",
"progressive",
"or",
"recurrent",
"despite",
"standard",
"care",
"including",
"surgery",
",",
"radiotherapy",
",",
"and/or",
"chemotherapy"
] |
[
0,
0,
0,
0,
3,
3,
0,
0,
3,
3,
0,
3,
3,
3,
0,
3,
3,
0,
3,
3,
3,
0,
3,
0,
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1
] |
NCT01568177
|
13:34:chronic_disease
|
significant aortic valve stenosis
| 1
|
[
"significant",
"aortic",
"valve",
"stenosis"
] |
[
0,
2,
2,
2
] |
NCT00862446
|
13:26:treatment,
|
Anticipated TPN treatment for at least one month
| 1
|
[
"Anticipated",
"TPN",
"treatment",
"for",
"at",
"least",
"one",
"month"
] |
[
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02098876
|
,,,,,50:61:chronic_disease,
|
Systolic BP >160mmHg or diastolic BP>100 mmHg or hypotension (BP <90/60 mmHg)
| 1
|
[
"Systolic",
"BP",
">",
"160mmHg",
"or",
"diastolic",
"BP",
">",
"100",
"mmHg",
"or",
"hypotension",
"(",
"BP",
"<",
"90/60",
"mmHg",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02237183
|
29:43:treatment,67:74:treatment,84:127:treatment
|
patients must not be taking anticoagulants, with the exception of aspirin or other non-steroidal anti-inflammatory medications
| 1
|
[
"patients",
"must",
"not",
"be",
"taking",
"anticoagulants",
",",
"with",
"the",
"exception",
"of",
"aspirin",
"or",
"other",
"non-steroidal",
"anti-inflammatory",
"medications"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
1
] |
NCT00501826
|
36:48:treatment
|
failure to one induction course of chemotherapy are eligible
| 1
|
[
"failure",
"to",
"one",
"induction",
"course",
"of",
"chemotherapy",
"are",
"eligible"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT02520791
|
25:43:treatment,
|
Receipt of live or live attenuated vaccine within 12 weeks prior to enrollment
| 1
|
[
"Receipt",
"of",
"live",
"or",
"live",
"attenuated",
"vaccine",
"within",
"12",
"weeks",
"prior",
"to",
"enrollment"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02232516
|
69:77:cancer
|
Patients who have known central nervous system (CNS) involvement of lymphoma
| 1
|
[
"Patients",
"who",
"have",
"known",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"involvement",
"of",
"lymphoma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02539160
|
12:22:cancer
|
Any active malignancy
| 1
|
[
"Any",
"active",
"malignancy"
] |
[
0,
0,
3
] |
NCT02479230
|
1:18:treatment,
|
Prior GEM therapy is acceptable as long as the last dose was ≥ 3 months from registration on this study
| 1
|
[
"Prior",
"GEM",
"therapy",
"is",
"acceptable",
"as",
"long",
"as",
"the",
"last",
"dose",
"was",
"≥",
"3",
"months",
"from",
"registration",
"on",
"this",
"study"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02219555
|
1:12:chronic_disease
|
amyloidosis
| 1
|
[
"amyloidosis"
] |
[
2
] |
NCT01969643
|
1:24:cancer,,71:95:treatment,330:346:treatment
|
Triple-negative disease (ER/PR/HER2-negative) and received at least 2 prior cytotoxic regimens in the incurable, unresectable, LA/MBC setting; or ER-positive and/or PR-positive/HER2-negative disease and received at least 2 prior cytotoxic regimens in the incurable, unresectable, LA/MBC setting and are no longer a candidate for hormonal therapy (not enrolling new patients)
| 1
|
[
"Triple-negative",
"disease",
"(",
"ER/PR/HER2-negative",
")",
"and",
"received",
"at",
"least",
"2",
"prior",
"cytotoxic",
"regimens",
"in",
"the",
"incurable",
",",
"unresectable",
",",
"LA/MBC",
"setting",
";",
"or",
"ER-positive",
"and/or",
"PR-positive/HER2-negative",
"disease",
"and",
"received",
"at",
"least",
"2",
"prior",
"cytotoxic",
"regimens",
"in",
"the",
"incurable",
",",
"unresectable",
",",
"LA/MBC",
"setting",
"and",
"are",
"no",
"longer",
"a",
"candidate",
"for",
"hormonal",
"therapy",
"(",
"not",
"enrolling",
"new",
"patients",
")"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01676259
|
1:13:treatment
|
chemotherapy
| 1
|
[
"chemotherapy"
] |
[
1
] |
NCT02639546
|
1:37:chronic_disease
|
Impaired gastrointestinal absorption
| 1
|
[
"Impaired",
"gastrointestinal",
"absorption"
] |
[
2,
2,
2
] |
NCT02583789
|
1:26:chronic_disease,28:45:chronic_disease,58:81:chronic_disease,83:97:chronic_disease,101:122:chronic_disease,,152:162:cancer,175:188:treatment
|
Uncontrolled hypertension, diabetes mellitus, history of orthostatic hypotension, acute coronary or cerebrovascular event within 3 months, evidence of malignancy, history of sympathectomy
| 1
|
[
"Uncontrolled",
"hypertension",
",",
"diabetes",
"mellitus",
",",
"history",
"of",
"orthostatic",
"hypotension",
",",
"acute",
"coronary",
"or",
"cerebrovascular",
"event",
"within",
"3",
"months",
",",
"evidence",
"of",
"malignancy",
",",
"history",
"of",
"sympathectomy"
] |
[
2,
2,
0,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
1
] |
NCT02263729
|
27:35:allergy_name,27:43:treatment,75:94:allergy_name
|
Has contraindications for Losartan therapy (hypersensitivity to Losartan, hepatic involvement)
| 1
|
[
"Has",
"contraindications",
"for",
"Losartan",
"therapy",
"(",
"hypersensitivity",
"to",
"Losartan",
",",
"hepatic",
"involvement",
")"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
4,
4,
0
] |
NCT00001379
|
12:36:chronic_disease
|
history of congestive heart failure will not be eligible to receive
| 1
|
[
"history",
"of",
"congestive",
"heart",
"failure",
"will",
"not",
"be",
"eligible",
"to",
"receive"
] |
[
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02030028
|
1:24:chronic_disease
|
Abnormal renal function
| 1
|
[
"Abnormal",
"renal",
"function"
] |
[
2,
2,
2
] |
NCT01505062
|
12:22:cancer,
|
History of malignancy within a five year period
| 1
|
[
"History",
"of",
"malignancy",
"within",
"a",
"five",
"year",
"period"
] |
[
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02989974
|
42:53:cancer
|
Individuals who have been diagnosed with lung cancer (survivor)
| 1
|
[
"Individuals",
"who",
"have",
"been",
"diagnosed",
"with",
"lung",
"cancer",
"(",
"survivor",
")"
] |
[
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0
] |
NCT02315196
|
,,58:71:cancer
|
Life expectancy >= 52 weeks excluding their diagnosis of breast cancer
| 1
|
[
"Life",
"expectancy",
">",
"=",
"52",
"weeks",
"excluding",
"their",
"diagnosis",
"of",
"breast",
"cancer"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT02016924
|
4:8:chronic_disease,
|
An AIDS defining condition with onset within 30 days prior to screening
| 1
|
[
"An",
"AIDS",
"defining",
"condition",
"with",
"onset",
"within",
"30",
"days",
"prior",
"to",
"screening"
] |
[
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02570672
|
28:41:chronic_disease,,,99:116:chronic_disease,118:125:chronic_disease,208:220:treatment
|
History of moderate-severe heart disease (New York Heart Classification greater than grade II) or pulmonary disease (dyspnea on exertion upon climbing one flight of stairs or less; abnormal breath sounds on auscultation)
| 1
|
[
"History",
"of",
"moderate-severe",
"heart",
"disease",
"(",
"New",
"York",
"Heart",
"Classification",
"greater",
"than",
"grade",
"II",
")",
"or",
"pulmonary",
"disease",
"(",
"dyspnea",
"on",
"exertion",
"upon",
"climbing",
"one",
"flight",
"of",
"stairs",
"or",
"less",
";",
"abnormal",
"breath",
"sounds",
"on",
"auscultation",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02562040
|
46:54:chronic_disease,56:66:chronic_disease,72:96:chronic_disease
|
Other severe chronic health problems such as diabetes, narcolepsy, and poorly controlled asthma
| 1
|
[
"Other",
"severe",
"chronic",
"health",
"problems",
"such",
"as",
"diabetes",
",",
"narcolepsy",
",",
"and",
"poorly",
"controlled",
"asthma"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
2,
2
] |
NCT01659541
|
1:38:chronic_disease
|
Spinal cord injury C8 level or higher
| 1
|
[
"Spinal",
"cord",
"injury",
"C8",
"level",
"or",
"higher"
] |
[
2,
2,
2,
2,
2,
2,
2
] |
NCT02474199
|
1:4:chronic_disease
|
HCV RNA negative at time of study enrollment
| 1
|
[
"HCV",
"RNA",
"negative",
"at",
"time",
"of",
"study",
"enrollment"
] |
[
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03181516
|
1:13:treatment
|
Trimethoprim
| 1
|
[
"Trimethoprim"
] |
[
1
] |
NCT02091999
|
12:35:treatment
|
History of corneal transplantation
| 1
|
[
"History",
"of",
"corneal",
"transplantation"
] |
[
0,
0,
1,
1
] |
NCT02530073
|
8:17:treatment
|
Normal Karyotype
| 1
|
[
"Normal",
"Karyotype"
] |
[
0,
1
] |
NCT01703949
|
,63:75:treatment
|
Patients must be anticipated to complete at least 2 cycles of chemotherapy on study
| 1
|
[
"Patients",
"must",
"be",
"anticipated",
"to",
"complete",
"at",
"least",
"2",
"cycles",
"of",
"chemotherapy",
"on",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT03126110
|
,54:67:treatment
|
Has not recovered to ≤ Grade 1 from toxic effects of prior therapy
| 1
|
[
"Has",
"not",
"recovered",
"to",
"≤",
"Grade",
"1",
"from",
"toxic",
"effects",
"of",
"prior",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02905370
|
1:28:chronic_disease
|
Peripheral Arterial Disease
| 1
|
[
"Peripheral",
"Arterial",
"Disease"
] |
[
2,
2,
2
] |
NCT02374021
|
4:22:treatment,,60:63:treatment,68:71:treatment
|
No non-biologic DMARDs in preceding two months (other than MTX and HCQ)
| 1
|
[
"No",
"non-biologic",
"DMARDs",
"in",
"preceding",
"two",
"months",
"(",
"other",
"than",
"MTX",
"and",
"HCQ",
")"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT03181126
|
,73:85:treatment
|
Refractory is defined as persistent disease after at least 2 courses of chemotherapy
| 1
|
[
"Refractory",
"is",
"defined",
"as",
"persistent",
"disease",
"after",
"at",
"least",
"2",
"courses",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01931202
|
35:47:treatment,
|
non-response to adequate trial of escitalopram (at least 4 weeks at dose of 20mg) during the current episode
| 1
|
[
"non-response",
"to",
"adequate",
"trial",
"of",
"escitalopram",
"(",
"at",
"least",
"4",
"weeks",
"at",
"dose",
"of",
"20mg",
")",
"during",
"the",
"current",
"episode"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02253316
|
13:20:chronic_disease,24:43:chronic_disease,132:141:treatment
|
Any serious medical or psychiatric illness that could, in the investigator's opinion, potentially interfere with the completion of treatment according to this protocol
| 1
|
[
"Any",
"serious",
"medical",
"or",
"psychiatric",
"illness",
"that",
"could",
",",
"in",
"the",
"investigator",
"'s",
"opinion",
",",
"potentially",
"interfere",
"with",
"the",
"completion",
"of",
"treatment",
"according",
"to",
"this",
"protocol"
] |
[
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02419495
|
,,,97:106:treatment,,
|
Negative serum pregnancy test in women of childbearing potential within 7 days of first dose of treatment and patients of child-bearing potential must agree to use effective contraception during/after 3 months post dose
| 1
|
[
"Negative",
"serum",
"pregnancy",
"test",
"in",
"women",
"of",
"childbearing",
"potential",
"within",
"7",
"days",
"of",
"first",
"dose",
"of",
"treatment",
"and",
"patients",
"of",
"child-bearing",
"potential",
"must",
"agree",
"to",
"use",
"effective",
"contraception",
"during/after",
"3",
"months",
"post",
"dose"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01872975
|
26:36:treatment,121:135:cancer,140:144:cancer
|
For patients who undergo lumpectomy, the margins of the resected specimen or re-excision must be histologically free of invasive tumor and DCIS as determined by the local pathologist
| 1
|
[
"For",
"patients",
"who",
"undergo",
"lumpectomy",
",",
"the",
"margins",
"of",
"the",
"resected",
"specimen",
"or",
"re-excision",
"must",
"be",
"histologically",
"free",
"of",
"invasive",
"tumor",
"and",
"DCIS",
"as",
"determined",
"by",
"the",
"local",
"pathologist"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT02135588
|
,,86:95:treatment
|
must have a negative urine or serum pregnancy test within 2 weeks prior to beginning treatment on this trial
| 1
|
[
"must",
"have",
"a",
"negative",
"urine",
"or",
"serum",
"pregnancy",
"test",
"within",
"2",
"weeks",
"prior",
"to",
"beginning",
"treatment",
"on",
"this",
"trial"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02382549
|
29:48:chronic_disease
|
Participants with an active autoimmune disorder requiring these therapies are also excluded
| 1
|
[
"Participants",
"with",
"an",
"active",
"autoimmune",
"disorder",
"requiring",
"these",
"therapies",
"are",
"also",
"excluded"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02525861
|
68:81:chronic_disease,,
|
The participant is experiencing or has a history of chronic severe cor pulmonale (resting mean pulmonary artery pressure ≥40 millimeter(s) of mercury (mm Hg))
| 1
|
[
"The",
"participant",
"is",
"experiencing",
"or",
"has",
"a",
"history",
"of",
"chronic",
"severe",
"cor",
"pulmonale",
"(",
"resting",
"mean",
"pulmonary",
"artery",
"pressure",
"≥40",
"millimeter",
"(",
"s",
")",
"of",
"mercury",
"(",
"mm",
"Hg",
")",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02349867
|
24:39:chronic_disease,57:76:chronic_disease,86:105:chronic_disease,116:140:chronic_disease,,,,197:220:chronic_disease,231:254:treatment,,281:302:chronic_disease,315:338:chronic_disease
|
Clinically significant cardiac disease, including major cardiac dysfunction, such as uncontrolled angina, clinical congestive heart failure with New York Heart Association (NYHA) class III or IV, ventricular arrhythmias requiring anti-arrhythmic therapy, recent (within 6 months) myocardial infarction or unstable coronary artery disease
| 1
|
[
"Clinically",
"significant",
"cardiac",
"disease",
",",
"including",
"major",
"cardiac",
"dysfunction",
",",
"such",
"as",
"uncontrolled",
"angina",
",",
"clinical",
"congestive",
"heart",
"failure",
"with",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"class",
"III",
"or",
"IV",
",",
"ventricular",
"arrhythmias",
"requiring",
"anti-arrhythmic",
"therapy",
",",
"recent",
"(",
"within",
"6",
"months",
")",
"myocardial",
"infarction",
"or",
"unstable",
"coronary",
"artery",
"disease"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2
] |
NCT02553941
|
1:11:cancer,25:40:treatment,,122:132:treatment
|
Malignancy treated with curative intent and with no known active disease present for >= 1 years before the first dose of study drug and felt to be at low risk for recurrence by treating physician
| 1
|
[
"Malignancy",
"treated",
"with",
"curative",
"intent",
"and",
"with",
"no",
"known",
"active",
"disease",
"present",
"for",
">",
"=",
"1",
"years",
"before",
"the",
"first",
"dose",
"of",
"study",
"drug",
"and",
"felt",
"to",
"be",
"at",
"low",
"risk",
"for",
"recurrence",
"by",
"treating",
"physician"
] |
[
3,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03112174
|
71:84:treatment,90:99:treatment,109:123:treatment
|
Concurrent enrollment in another therapeutic investigational study or prior therapy with ibrutinib or other BTK inhibitors
| 1
|
[
"Concurrent",
"enrollment",
"in",
"another",
"therapeutic",
"investigational",
"study",
"or",
"prior",
"therapy",
"with",
"ibrutinib",
"or",
"other",
"BTK",
"inhibitors"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
1
] |
NCT02446093
|
13:37:treatment
|
Patients on systemic corticosteroids
| 1
|
[
"Patients",
"on",
"systemic",
"corticosteroids"
] |
[
0,
0,
1,
1
] |
NCT01760655
|
55:65:cancer
|
Active involvement of the central nervous system with malignancy
| 1
|
[
"Active",
"involvement",
"of",
"the",
"central",
"nervous",
"system",
"with",
"malignancy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02402088
|
5:23:chronic_disease,105:128:treatment,141:157:chronic_disease,162:179:chronic_disease
|
Any psychotic disorder or current psychiatric symptoms requiring specific attention, including need for psychiatric medications for current major depression and anxiety disorders
| 1
|
[
"Any",
"psychotic",
"disorder",
"or",
"current",
"psychiatric",
"symptoms",
"requiring",
"specific",
"attention",
",",
"including",
"need",
"for",
"psychiatric",
"medications",
"for",
"current",
"major",
"depression",
"and",
"anxiety",
"disorders"
] |
[
0,
2,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2
] |
NCT02493426
|
25:44:treatment
|
Individuals that are on antipsychotic drugs will be excluded from participation. All subjects must lack a significant medical history
| 1
|
[
"Individuals",
"that",
"are",
"on",
"antipsychotic",
"drugs",
"will",
"be",
"excluded",
"from",
"participation",
".",
"All",
"subjects",
"must",
"lack",
"a",
"significant",
"medical",
"history"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01684397
|
36:46:treatment
|
Ability to swallow and retain oral medication
| 1
|
[
"Ability",
"to",
"swallow",
"and",
"retain",
"oral",
"medication"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT02074631
|
1:23:chronic_disease,34:73:chronic_disease,84:113:chronic_disease,115:133:chronic_disease,135:155:chronic_disease,157:176:chronic_disease,177:200:chronic_disease,223:236:treatment
|
Non-malignant diseases including idiopathic severe aplastic anemia (SAA) and other bone marrow failure disorders, hemoglobinopathies, adrenoleukodystrophy, immune deficiencies/dysregulation disorders who will be receiving myeloablative or reduced toxicity preparative regimens that meet the following criteria
| 1
|
[
"Non-malignant",
"diseases",
"including",
"idiopathic",
"severe",
"aplastic",
"anemia",
"(",
"SAA",
")",
"and",
"other",
"bone",
"marrow",
"failure",
"disorders",
",",
"hemoglobinopathies",
",",
"adrenoleukodystrophy",
",",
"immune",
"deficiencies/dysregulation",
"disorders",
"who",
"will",
"be",
"receiving",
"myeloablative",
"or",
"reduced",
"toxicity",
"preparative",
"regimens",
"that",
"meet",
"the",
"following",
"criteria"
] |
[
2,
2,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
2,
2,
2,
2,
0,
2,
0,
2,
0,
2,
2,
2,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02100891
|
,,,110:119:treatment,
|
Fertile females who are unwilling to use contraceptive techniques during and for the twelve months following treatment, as well as females who are pregnant or actively breast feeding
| 1
|
[
"Fertile",
"females",
"who",
"are",
"unwilling",
"to",
"use",
"contraceptive",
"techniques",
"during",
"and",
"for",
"the",
"twelve",
"months",
"following",
"treatment",
",",
"as",
"well",
"as",
"females",
"who",
"are",
"pregnant",
"or",
"actively",
"breast",
"feeding"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01364363
|
,,19:45:treatment
|
Weight < 70kg for cord blood transplantation
| 1
|
[
"Weight",
"<",
"70kg",
"for",
"cord",
"blood",
"transplantation"
] |
[
0,
0,
0,
0,
1,
1,
1
] |
NCT02259621
|
,,51:67:chronic_disease,,
|
Total Bilirubin ≤ 1.5 x ULN (except subjects with Gilbert Syndrome, who can have total bilirubin < 3.0 mg/dL)
| 1
|
[
"Total",
"Bilirubin",
"≤",
"1.5",
"x",
"ULN",
"(",
"except",
"subjects",
"with",
"Gilbert",
"Syndrome",
",",
"who",
"can",
"have",
"total",
"bilirubin",
"<",
"3.0",
"mg/dL",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02516332
|
1:16:chronic_disease
|
Unstable angina
| 1
|
[
"Unstable",
"angina"
] |
[
2,
2
] |
NCT02501473
|
60:74:cancer
|
In Part 4, enrollment is limited to relapsed or refractory follicular NHL patients
| 1
|
[
"In",
"Part",
"4",
",",
"enrollment",
"is",
"limited",
"to",
"relapsed",
"or",
"refractory",
"follicular",
"NHL",
"patients"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0
] |
NCT02143830
|
,,60:70:treatment,
|
Women must be willing to undergo a pregnancy test prior to transplant and avoid becoming pregnant while on study
| 1
|
[
"Women",
"must",
"be",
"willing",
"to",
"undergo",
"a",
"pregnancy",
"test",
"prior",
"to",
"transplant",
"and",
"avoid",
"becoming",
"pregnant",
"while",
"on",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02688569
|
22:66:treatment
|
participation in any nonpharmacological treatment (including CBT) for pain, sleep, fatigue, or mood outside the current study
| 1
|
[
"participation",
"in",
"any",
"nonpharmacological",
"treatment",
"(",
"including",
"CBT",
")",
"for",
"pain",
",",
"sleep",
",",
"fatigue",
",",
"or",
"mood",
"outside",
"the",
"current",
"study"
] |
[
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01515527
|
74:86:treatment
|
Patient with documented hypersensitivity to any of the components of the chemotherapy program
| 1
|
[
"Patient",
"with",
"documented",
"hypersensitivity",
"to",
"any",
"of",
"the",
"components",
"of",
"the",
"chemotherapy",
"program"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT03085485
|
1:31:chronic_disease
|
stable coronary artery disease
| 1
|
[
"stable",
"coronary",
"artery",
"disease"
] |
[
2,
2,
2,
2
] |
NCT02152995
|
1:4:treatment
|
RAI-refractory disease on structural imaging
| 1
|
[
"RAI-refractory",
"disease",
"on",
"structural",
"imaging"
] |
[
1,
0,
0,
0,
0
] |
NCT01990209
|
24:40:chronic_disease,,,,
|
in patients with known Gilbert Syndrome, a total bilirubin ≤3.0 x ULN, with direct bilirubin ≤1.5 x ULN
| 1
|
[
"in",
"patients",
"with",
"known",
"Gilbert",
"Syndrome",
",",
"a",
"total",
"bilirubin",
"≤3.0",
"x",
"ULN",
",",
"with",
"direct",
"bilirubin",
"≤1.5",
"x",
"ULN"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02487095
|
37:66:chronic_disease,213:232:chronic_disease,234:245:chronic_disease,247:258:chronic_disease,260:281:chronic_disease,283:308:chronic_disease,310:346:chronic_disease,348:372:chronic_disease,374:395:chronic_disease,,422:453:chronic_disease,455:486:chronic_disease,516:553:chronic_disease
|
Subjects with evidence of severe or uncontrolled systemic disease, or any concurrent condition, which could compromise participation in the study, including, but not limited to, active or uncontrolled infection, immune deficiencies, Hepatitis B, Hepatitis C, uncontrolled diabetes, uncontrolled hypertension, symptomatic congestive heart failure, unstable angina pectoris, myocardial infarction within the past 6 months, uncontrolled cardiac arrhythmia, stroke/cerebrovascular accident within the past 6 months, or psychiatric illness/social situations which would jeopardize compliance with the protocol
| 1
|
[
"Subjects",
"with",
"evidence",
"of",
"severe",
"or",
"uncontrolled",
"systemic",
"disease",
",",
"or",
"any",
"concurrent",
"condition",
",",
"which",
"could",
"compromise",
"participation",
"in",
"the",
"study",
",",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"active",
"or",
"uncontrolled",
"infection",
",",
"immune",
"deficiencies",
",",
"Hepatitis",
"B",
",",
"Hepatitis",
"C",
",",
"uncontrolled",
"diabetes",
",",
"uncontrolled",
"hypertension",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"myocardial",
"infarction",
"within",
"the",
"past",
"6",
"months",
",",
"uncontrolled",
"cardiac",
"arrhythmia",
",",
"stroke/cerebrovascular",
"accident",
"within",
"the",
"past",
"6",
"months",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"which",
"would",
"jeopardize",
"compliance",
"with",
"the",
"protocol"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01898793
|
1:24:treatment,35:48:treatment,52:63:treatment
|
cytoreductive therapies including leukapheresis or hydroxyurea
| 1
|
[
"cytoreductive",
"therapies",
"including",
"leukapheresis",
"or",
"hydroxyurea"
] |
[
1,
1,
0,
1,
0,
1
] |
NCT03181893
|
61:76:treatment
|
failed at least 1 standard of care systemic treatment, (eg, corticosteroids)
| 1
|
[
"failed",
"at",
"least",
"1",
"standard",
"of",
"care",
"systemic",
"treatment",
",",
"(",
"eg",
",",
"corticosteroids",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02707471
|
28:37:treatment,45:52:treatment,54:66:treatment,68:77:treatment
|
completed local definitive treatment (i.e., surgery, chemotherapy, radiation)
| 1
|
[
"completed",
"local",
"definitive",
"treatment",
"(",
"i.e.",
",",
"surgery",
",",
"chemotherapy",
",",
"radiation",
")"
] |
[
0,
0,
0,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0
] |
NCT02520427
|
28:51:treatment
|
Unresolved toxicities from prior antitumor therapy, defined as not having resolved to CTCAE, version 4.0 grade 1
| 1
|
[
"Unresolved",
"toxicities",
"from",
"prior",
"antitumor",
"therapy",
",",
"defined",
"as",
"not",
"having",
"resolved",
"to",
"CTCAE",
",",
"version",
"4.0",
"grade",
"1"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01804634
|
,,51:60:treatment,62:74:treatment,78:99:treatment,101:110:treatment
|
Patients with >5 identified lesions on the end of induction (COG ANBL0532 or standard chemotherapy) MIBG scan
| 1
|
[
"Patients",
"with",
">",
"5",
"identified",
"lesions",
"on",
"the",
"end",
"of",
"induction",
"(",
"COG",
"ANBL0532",
"or",
"standard",
"chemotherapy",
")",
"MIBG",
"scan"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
1,
0,
1,
1
] |
NCT02543866
|
30:64:chronic_disease,92:112:treatment,103:112:treatment
|
Patients with current active ESC-R Enterobacteriaceae infection who have not yet completed antibiotic treatment will be excluded until their treatment is completed
| 1
|
[
"Patients",
"with",
"current",
"active",
"ESC-R",
"Enterobacteriaceae",
"infection",
"who",
"have",
"not",
"yet",
"completed",
"antibiotic",
"treatment",
"will",
"be",
"excluded",
"until",
"their",
"treatment",
"is",
"completed"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02947945
|
30:70:treatment,48:51:treatment,,188:194:treatment,,
|
Subjects who have received a cyclophosphamide (CYC) induction regimen may be included a minimum of 2 weeks after the last dose of daily oral CYC, or 3 weeks after the last dose of pulsed IV CYC prior to visit 1, if their total WBC is ≥4x109/L prior to visit 1
| 1
|
[
"Subjects",
"who",
"have",
"received",
"a",
"cyclophosphamide",
"(",
"CYC",
")",
"induction",
"regimen",
"may",
"be",
"included",
"a",
"minimum",
"of",
"2",
"weeks",
"after",
"the",
"last",
"dose",
"of",
"daily",
"oral",
"CYC",
",",
"or",
"3",
"weeks",
"after",
"the",
"last",
"dose",
"of",
"pulsed",
"IV",
"CYC",
"prior",
"to",
"visit",
"1",
",",
"if",
"their",
"total",
"WBC",
"is",
"≥4x109/L",
"prior",
"to",
"visit",
"1"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02397889
|
29:38:chronic_disease
|
Past or current presence of psychotic symptoms
| 1
|
[
"Past",
"or",
"current",
"presence",
"of",
"psychotic",
"symptoms"
] |
[
0,
0,
0,
0,
0,
2,
0
] |
NCT02361554
|
29:84:treatment,
|
Subject has participated in another investigational drug trial or therapeutic trial within 30 days of Baseline Visit
| 1
|
[
"Subject",
"has",
"participated",
"in",
"another",
"investigational",
"drug",
"trial",
"or",
"therapeutic",
"trial",
"within",
"30",
"days",
"of",
"Baseline",
"Visit"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02456857
|
18:52:chronic_disease
|
Known history of human immunodeficiency virus (HIV) seropositivity
| 1
|
[
"Known",
"history",
"of",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"seropositivity"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT02107703
|
,56:73:treatment,81:99:treatment,104:122:cancer
|
Participants may not have received more than 1 line of endocrine therapy or any prior chemotherapy for metastatic disease
| 1
|
[
"Participants",
"may",
"not",
"have",
"received",
"more",
"than",
"1",
"line",
"of",
"endocrine",
"therapy",
"or",
"any",
"prior",
"chemotherapy",
"for",
"metastatic",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
0,
3,
3
] |
NCT03109431
|
23:26:chronic_disease
|
Acutely infected with HIV
| 1
|
[
"Acutely",
"infected",
"with",
"HIV"
] |
[
0,
0,
0,
2
] |
NCT02842658
|
9:32:chronic_disease
|
Complex ventricular arrhythmias
| 1
|
[
"Complex",
"ventricular",
"arrhythmias"
] |
[
0,
2,
2
] |
NCT02337465
|
1:16:cancer,20:26:treatment,74:91:treatment
|
prostate cancer by biopsy, with the intent of undergoing definitive dose radiation therapy to targets within the liver, or prostate
| 1
|
[
"prostate",
"cancer",
"by",
"biopsy",
",",
"with",
"the",
"intent",
"of",
"undergoing",
"definitive",
"dose",
"radiation",
"therapy",
"to",
"targets",
"within",
"the",
"liver",
",",
"or",
"prostate"
] |
[
3,
3,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02114229
|
24:46:chronic_disease
|
Presence of an active, uncontrolled infection
| 1
|
[
"Presence",
"of",
"an",
"active",
",",
"uncontrolled",
"infection"
] |
[
0,
0,
0,
0,
0,
2,
2
] |
NCT02177695
|
,37:60:treatment
|
disease measuring at least 10 mm on cross-sectional imaging
| 1
|
[
"disease",
"measuring",
"at",
"least",
"10",
"mm",
"on",
"cross-sectional",
"imaging"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01558544
|
1:8:treatment,81:106:treatment,110:114:cancer
|
Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients
| 1
|
[
"Surgery",
"that",
"requires",
"removal",
"of",
"ovaries",
"for",
"medical",
"condition",
"or",
"disease",
",",
"e.g",
".",
"Prophylactic",
"oophorectomy",
"in",
"BRCA",
"patients"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
3,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.